Leukemia & Lymphoma Society | Specialized Center of Research (SCOR)
Event details
| Date | 06.12.2024 |
| Category | Call for proposal |
Aim: LLS’s Specialized Center of Research (SCOR) grant program is intended to bring together established investigators from one or several institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisciplinary research among the participants. The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of hematological malignancies. Strategies that move discoveries from the bench to the clinic are of high importance as are integrated translational projects.
A major emphasis in the SCOR grant program is on clinical translation of scientific results. Ideally, a SCOR application will propose a combination of basic and translational laboratory research that will lead to eventual clinical translation. There should be clear and direct “bench to bedside” translational trajectory from one or more of the Projects in the SCOR. It is important to note that the inclusion of a clinical trial in and of itself may not satisfy this requirement. Any clinical translation must be a coherent and integrated extension of other SCOR activities, and there should be substantive interactions and synergy between clinical trials and more basic or early translational Projects in the SCOR.
Each SCOR is comprised of 3-5 scientific Projects, an Administrative Core and 2-4 supportive scientific Cores. There must be objective evidence of interdisciplinary research and the potential for synergism by linking the various Projects and Cores into a SCOR team. The quality and significance of the Projects and Cores and the enhanced productivity that is likely to be achieved by linking investigators are primary determinants of funding decisions.
A SCOR team will be judged as a unit and funding will not be available for otherwise meritorious but non-synergistic parts of an application.
Please note that LLS’s Terms and Conditions are non-negotiable and include strict IP rules. Please contact the ReO for more info prior to submission.
Funding: $5,000,000
Duration: 5 years
Eligibility: The program welcomes applications worldwide from appropriate academic institutions and investigators of any nationality. Applicants must hold a PhD, MD, DVM, or equivalent degree and must be affiliated with a nonprofit Institution at the time funding commences and for the duration of the award.
How to Apply: The 2-stage application process begins with a Letter of Intent, to be submitted on the LLS Research Portal.
Deadline, Letter of Intent: 6 December 2024
Deadline, Full Application: 31 March 2025
Further information:
A major emphasis in the SCOR grant program is on clinical translation of scientific results. Ideally, a SCOR application will propose a combination of basic and translational laboratory research that will lead to eventual clinical translation. There should be clear and direct “bench to bedside” translational trajectory from one or more of the Projects in the SCOR. It is important to note that the inclusion of a clinical trial in and of itself may not satisfy this requirement. Any clinical translation must be a coherent and integrated extension of other SCOR activities, and there should be substantive interactions and synergy between clinical trials and more basic or early translational Projects in the SCOR.
Each SCOR is comprised of 3-5 scientific Projects, an Administrative Core and 2-4 supportive scientific Cores. There must be objective evidence of interdisciplinary research and the potential for synergism by linking the various Projects and Cores into a SCOR team. The quality and significance of the Projects and Cores and the enhanced productivity that is likely to be achieved by linking investigators are primary determinants of funding decisions.
A SCOR team will be judged as a unit and funding will not be available for otherwise meritorious but non-synergistic parts of an application.
Please note that LLS’s Terms and Conditions are non-negotiable and include strict IP rules. Please contact the ReO for more info prior to submission.
Funding: $5,000,000
Duration: 5 years
Eligibility: The program welcomes applications worldwide from appropriate academic institutions and investigators of any nationality. Applicants must hold a PhD, MD, DVM, or equivalent degree and must be affiliated with a nonprofit Institution at the time funding commences and for the duration of the award.
How to Apply: The 2-stage application process begins with a Letter of Intent, to be submitted on the LLS Research Portal.
Deadline, Letter of Intent: 6 December 2024
Deadline, Full Application: 31 March 2025
Further information:
- More information about the program, guidelines, and instructions are available here
- The application portal can be found here
- For any other questions, please contact the Research Office
Practical information
- General public
- Free